GlassScriptPhysician profile
Kimberly E Gardner
NPI 1306264841
$220.51
in general payments reported to CMS, 2019-2025
7 companies · $28.18 in 2025
The $28.18 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $56.14 · 2023: $58.94 · 2024: $77.25 · 2025: $28.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $164.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $59.48 | 2021-2024 | Keytruda |
| Seagen INC. | $40.01 | 2023 | Tukysa |
| Genentech USA, INC. | $31.25 | 2024 | Rozlytrek, Tecentriq, Avastin |
| Novartis Pharmaceuticals Corporation | $28.18 | 2025 | |
| Incyte Corporation | $24.38 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $18.93 | 2023 | Imfinzi |
| Janssen Pharmaceuticals, INC | $18.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Gardner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.